Evaluation of clinical prediction models (part 2): how to undertake an external validation study

Evaluation of clinical prediction models (part 2): how to undertake an external validation study

External validation studies are an important but often neglected part of prediction model research. In this article, the second in a series on model evaluation, Riley and colleagues explain what an external validation study entails and describe the key steps involved, from establishing a high qualit...

Detaylı Bibliyografya
Asıl Yazarlar:	Riley, RD, Archer, L, Snell, KIE, Ensor, J, Dhiman, P, Martin, GP, Bonnett, LJ, Collins, GS
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BMJ Publishing Group 2024

Benzer Materyaller

External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb
Yazar:: Snell, KIE, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Minimum sample size for external validation of a clinical prediction model with a continuous outcome
Yazar:: Archer, L, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Minimum sample size for external validation of a clinical prediction model with a binary outcome
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Evaluation of clinical prediction models (part 1): from development to external validation
Yazar:: Collins, GS, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Penalization and shrinkage methods produced unreliable clinical prediction models especially when sample size was small
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Clinical prediction models and the multiverse of madness
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Targeted validation: validating clinical prediction models in their intended population and setting
Yazar:: Sperrin, M, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Calculating the sample size required for developing a clinical prediction model
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges
Yazar:: Riley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist
Yazar:: Debray, TPA, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Transparent reporting of multivariable prediction models developed or validated using clustered data (TRIPOD-Cluster): explanation and elaboration
Yazar:: Debray, TPA, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Calculating the power of a planned individual participant data meta‐analysis to examine prognostic factor effects for a binary outcome
Yazar:: Whittle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Minimum sample size for developing a multivariable prediction model using multinomial logistic regression
Yazar:: Pate, A, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
Yazar:: Archer, L, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA)
Yazar:: Snell, KIE, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Developing clinical prediction models when adhering to minimum sample size recommendations: the importance of quantifying bootstrap variability in tuning parameters and predictive performance
Yazar:: Martin, GP, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Transfer of Undertakings and Insolvency
Yazar:: Collins, H
Baskı/Yayın Bilgisi: (1989)

Risk of bias assessments in individual participant data meta-analyses of test accuracy and prediction models: a review shows improvements are needed
Yazar:: Levis, B, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Minimum sample size for developing a multivariable prediction model: Part I – Continuous outcomes
Yazar:: Riley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Flaws in the development and validation of a covid-19 prediction model
Yazar:: Collins, GS, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Guide to presenting clinical prediction models for use in clinical settings.
Yazar:: Bonnett, L, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes
Yazar:: Riley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Calculating the power of a planned individual participant data meta-analysis of randomised trials to examine a treatment-covariate interaction with a time-to-event outcome
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Calculating the power to examine treatment-covariate interactions when planning an individual participant data meta-analysis of randomized trials with a binary outcome
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

There are no shortcuts in the development and validation of a COVID‐19 prediction model
Yazar:: Collins, GS, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Stability of clinical prediction models developed using statistical or machine learning methods
Yazar:: Riley, RD, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Why and how governments across the globe undertake electronic government.
Yazar:: Chiam, Bee Kuan., ve diğerleri
Baskı/Yayın Bilgisi: (2009)

How to Undertake Aging in a Healthy Way: Changes and Opportunities
Yazar:: Carla Chacón Valera, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

How to Undertake Aging in a Healthy Way: Changes and Opportunities
Yazar:: Carla Chacón Valera, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Continual updating and monitoring of clinical prediction models: time for dynamic prediction systems?
Yazar:: Jenkins, DA, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Conditions and Motivations to Undertake
Yazar:: Flor Ángela Marulanda Valencia, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01)

An undertaking of legacy and innovation
Yazar:: Daqing Li, M.D.
Baskı/Yayın Bilgisi: (2015-09-01)

How to undertake procedures while on antiplatelet agents: a hematologist's view
Yazar:: Dawn Swan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Predicting the risk of falls in patients with an indication for antihypertensive treatment: development and validation of the stratify-falls prediction model
Yazar:: Archer, L, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
Yazar:: Koshiaris, C, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Undertaking Empirically-Engaged African Philosophy: The Development and Validation of the African Time Inventory
Yazar:: Aïda C. Terblanché-Greeff, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Single-Undertaking and Sectoral Approach
Yazar:: Jeong-Yoo Kim
Baskı/Yayın Bilgisi: (2001-06-01)

Innovative undertakings in the Polish industry
Yazar:: Jan Zwolak
Baskı/Yayın Bilgisi: (2016-06-01)

Perceived stress and readiness to undertake biodebridement in the group of nurses undertaking prevention and treatment of chronic wounds
Yazar:: Joanna Przybek Mita, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)